© Reuters.
PLEASANTON, CA, USA – 10x Genomics, Inc. (NASDAQ:TXG), a specialist in single cell and spatial biology, announced that it has begun shipping two new products incorporating its GEM-X technology.
Named ‘Chromium Single Cell Gene Expression 3’ v4’ and ‘Chromium Single Cell Immune Profiling 5’ v3’, these products are designed to provide improved performance and cost-effectiveness in single cell analysis.
GEM-X technology, exclusively compatible with Chromium X series instruments, is described as a quantum leap forward in single cell technology architecture. New microfluidic chip designs and optimized reagents are integrated to enhance research capabilities.
Benefits include doubling the sensitivity of gene detection, doubling the number of cells that can be captured per channel, and reducing the cost per cell by more than half. Additionally, the multiplet ratio has been reduced by a factor of 2, enhancing data quality and improving sample recovery rates by up to 80%.
Researchers anticipate that GEM-X’s improved transcriptome capture capabilities will help distinguish cell types, identify rare cells, and decipher regulatory pathways more accurately.
Associate Professor Luciano Martelotto, from the University of Adelaide, emphasized the importance of identifying more genes per cell to enrich our understanding of cellular function and biological complexity.
10x Genomics is a life science technology company that aims to improve human health by providing integrated solutions in single cell and spatial biology. The company’s products are used in a variety of fields, including oncology, immunology, and neuroscience, contributing to important scientific discoveries.
Although the Company’s forward-looking statements represent plans for additional product launches and advancements in its pipeline, they are subject to a number of factors and uncertainties that could affect actual results and results. This press release is based on information available as of the date of writing and is used by 10x Genomics to comply with its disclosure obligations.
This shipping announcement marks an important milestone in 10x Genomics’ efforts to make single-cell analysis more accessible to the wider scientific community. This news is based on a press release from 10x Genomics.
This article was created and translated with the assistance of AI and reviewed by an editor. Please see our Terms of Use for more details.
